Inventor
Kenan Christopher GARCIA
Inventor
US
Overview
Patents· 22 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides24%
A61KPreparations for medical, dental or toiletry purposes21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
C12NMicroorganisms or enzymes9%
G01NInvestigating or analysing materials by determining their chemical or physical properties9%
Y02ATechnologies for adaptation to climate change7%
C07BGeneral methods of organic chemistry4%
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology4%
C12YEnzymes2%
G09GArrangements or circuits for control of indicating devices using static means to present variable information1%
PatentTitleYear
12,590,133IL-13/IL-4 superkines: immune cell targeting constructs and methods of use thereof202612,466,868Engineered proteins to enhance sensitivity of a cell to IL-2202512,410,226Interferon-gamma biased agonists202512,240,880De novo design of potent and selective interleukin mimetics202512,227,553De novo design of potent and selective interleukin mimetics202512,221,469Switch receptors using IL-9 signaling domains202512,195,532High affinity SIRP-alpha reagents and methods of using202512,091,441Partial agonists of interleukin-2202412,084,684Frizzled specific Wnt agonists and antagonists202412,006,347Superagonists and antagonists of interleukin-2202412,005,079Biologically relevant orthogonal cytokine/receptor pairs202411,993,645Compositions comprising R-Spondin (RSPO) surrogate molecules202411,993,639Therapeutic IL-13 polypeptides202411,846,639Ligand discovery for T cell receptors202311,780,899Engineered proteins to enhance sensitivity of a cell to IL-2202311,655,278De novo design of potent and selective interleukin mimetics202311,439,664Biologically relevant orthogonal cytokine/receptor pairs202211,401,313De novo design of potent and selective interleukin mimetics202211,261,250Bi-specific molecule for cell-specific Notch inhibition and related methods and compositions202211,208,481High affinity SIRP-alpha reagents and methods of using202111,198,717Variant type III interferons and synthekines202111,142,577WNT signaling agonist molecules2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2026Patents assigned to UNIV LELAND STANFORD JUNIOR (22)· patent assignee history
2021–2025Patents assigned to UNIV WASHINGTON (8)· patent assignee history
2021–2026Based in US· patent location history
2022Patents assigned to HUTCHINSON FRED CANCER RES (1)· patent assignee history
2023–2025Patents assigned to PARKER INST FOR CANCER IMMUNOTHERAPY (3)· patent assignee history
2023Patents assigned to CALIFORNIA INST OF TECHN (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV LELAND STANFORD JUNIOR | 22 | 2021–2026 |
| UNIV WASHINGTON | 8 | 2021–2025 |
| PARKER INST FOR CANCER IMMUNOTHERAPY | 3 | 2023–2025 |
| CALIFORNIA INST OF TECHN | 1 | 2023 |
| HUTCHINSON FRED CANCER RES | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 22 | 2021–2026 |